Does your patient have any of the following?
1) tumor profiling test result that shows a mutation (pathogenic variant) in a hereditary cancer susceptibility gene, or
2) blood relative with a known pathogenic variant in a cancer susceptibility gene such as BRCA1, BRCA2, the Lynch syndrome genes (MLH1, MSH2, MSH6, PMS2, EPCAM), or others
Has your patient ever been diagnosed with cancer or polyps?